DRMTY Stock DR MARTENS (DRMTY, $1.96) was a top weekly gainer, with a +7.42% jump

GET DAILY SIGNALS

Get AI intraday signals

DRMTY - DR MARTENS PLC

Loading...

Price: $1.955

Daily change: +$0.135 (+7.42%)

Daily volume: 600

Weekly price change: +$0.135 (+7.42%)

Capitalization: $977.4M

Industry: Wholesale Distributors

DR MARTENS (DRMTY, $1.96) was one of the top gainers this week, climbing to $1.96 per share. A.I.dvisor analyzed 34 stocks in the Wholesale Distributors Industry over the last week and discovered that of them (8) trended up while of them (1) trended down.

DRMTY's Stochastic Oscillator stays in oversold zone for 1 day

Be on the lookout for a price bounce soon.

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for DRMTY crossed bullishly above the 50-day moving average on January 12, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 99 cases where DRMTY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for DRMTY moved out of overbought territory on January 09, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 similar instances where the indicator moved out of overbought territory. In of the 15 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

DRMTY moved below its 50-day moving average on January 09, 2026 date and that indicates a change from an upward trend to a downward trend.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.144) is normal, around the industry mean (3.272). P/E Ratio (42.940) is within average values for comparable stocks, (32.239). DRMTY's Projected Growth (PEG Ratio) (0.012) is slightly lower than the industry average of (1.920). Dividend Yield (0.034) settles around the average of (0.033) among similar stocks. P/S Ratio (0.931) is also within normal values, averaging (1.355).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DRMTY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DRMTY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.